Crinetics Pharmaceuticals executives discussed Q1 2025 financial results

Crinetics Pharmaceuticals held its first quarter 2025 earnings call on Thursday, May 8th, to discuss financial results and company updates. The call included executives detailing the company's performance and future plans. Key participants included CEO Scott Struthers, Chief Commercial Officer Isabel Kalofonos, and CFO Toby Schilke. The call covered financial results, clinical trial progress, and commercial strategies. The earnings call provided an opportunity for analysts to ask questions and gain insights into Crinetics' operations. A slide deck and press release were available on the company's website.